BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 27774502)

  • 21. Engineered polymeric nanoparticles to guide the cellular internalization and trafficking of small interfering ribonucleic acids.
    Arnold AE; Czupiel P; Shoichet M
    J Control Release; 2017 Aug; 259():3-15. PubMed ID: 28232223
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel targeted siRNA-loaded hybrid nanoparticles: preparation, characterization and in vitro evaluation.
    Dim N; Perepelyuk M; Gomes O; Thangavel C; Liu Y; Den R; Lakshmikuttyamma A; Shoyele SA
    J Nanobiotechnology; 2015 Sep; 13():61. PubMed ID: 26410728
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The packaging of siRNA within the mesoporous structure of silica nanoparticles.
    Li X; Xie QR; Zhang J; Xia W; Gu H
    Biomaterials; 2011 Dec; 32(35):9546-56. PubMed ID: 21906804
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mechanistic insights into LDL nanoparticle-mediated siRNA delivery.
    Jin H; Lovell JF; Chen J; Lin Q; Ding L; Ng KK; Pandey RK; Manoharan M; Zhang Z; Zheng G
    Bioconjug Chem; 2012 Jan; 23(1):33-41. PubMed ID: 22142191
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Layer-by-layer nanoparticles as an efficient siRNA delivery vehicle for SPARC silencing.
    Tan YF; Mundargi RC; Chen MH; Lessig J; Neu B; Venkatraman SS; Wong TT
    Small; 2014 May; 10(9):1790-8. PubMed ID: 24510544
    [TBL] [Abstract][Full Text] [Related]  

  • 26. From Pulmonary Surfactant, Synthetic KL4 Peptide as Effective siRNA Delivery Vector for Pulmonary Delivery.
    Qiu Y; Chow MYT; Liang W; Chung WWY; Mak JCW; Lam JKW
    Mol Pharm; 2017 Dec; 14(12):4606-4617. PubMed ID: 29121767
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Kinetic analysis of the intracellular processing of siRNAs by confocal microscopy.
    Vocelle D; Chesniak OM; Smith MR; Chan C; Walton SP
    Microscopy (Oxf); 2020 Dec; 69(6):401-407. PubMed ID: 32525202
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nanoparticles for targeted delivery of therapeutics and small interfering RNAs in hepatocellular carcinoma.
    Varshosaz J; Farzan M
    World J Gastroenterol; 2015 Nov; 21(42):12022-41. PubMed ID: 26576089
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sustained delivery of siRNA/mesoporous silica nanoparticle complexes from nanofiber scaffolds for long-term gene silencing.
    Pinese C; Lin J; Milbreta U; Li M; Wang Y; Leong KW; Chew SY
    Acta Biomater; 2018 Aug; 76():164-177. PubMed ID: 29890267
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Autophagy plays a dual role during intracellular siRNA delivery by lipoplex and polyplex nanoparticles.
    Song W; Ma Z; Zhang Y; Yang C
    Acta Biomater; 2017 Aug; 58():196-204. PubMed ID: 28528119
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of antibody-modified chitosan nanoparticles for the targeted delivery of siRNA across the blood-brain barrier as a strategy for inhibiting HIV replication in astrocytes.
    Gu J; Al-Bayati K; Ho EA
    Drug Deliv Transl Res; 2017 Aug; 7(4):497-506. PubMed ID: 28315051
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A peptide-targeted delivery system with pH-sensitive amphiphilic cell membrane disruption for efficient receptor-mediated siRNA delivery.
    Wang XL; Xu R; Lu ZR
    J Control Release; 2009 Mar; 134(3):207-13. PubMed ID: 19135104
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cell Type-Specific Delivery of RNAi by Ligand-Functionalized Curdlan Nanoparticles: Balancing the Receptor Mediation and the Charge Motivation.
    Wu Y; Cai J; Han J; Baigude H
    ACS Appl Mater Interfaces; 2015 Sep; 7(38):21521-8. PubMed ID: 26345600
    [TBL] [Abstract][Full Text] [Related]  

  • 34. RNA interference technology with emphasis on delivery vehicles-prospects and limitations.
    Prabha S; Vyas R; Gupta N; Ahmed B; Chandra R; Nimesh S
    Artif Cells Nanomed Biotechnol; 2016 Sep; 44(6):1391-9. PubMed ID: 26140615
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enhanced cellular uptake and gene silencing activity of siRNA using temperature-responsive polymer-modified liposome.
    Wang J; Ayano E; Maitani Y; Kanazawa H
    Int J Pharm; 2017 May; 523(1):217-228. PubMed ID: 28330734
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chemical and structural modifications of RNAi therapeutics.
    Ku SH; Jo SD; Lee YK; Kim K; Kim SH
    Adv Drug Deliv Rev; 2016 Sep; 104():16-28. PubMed ID: 26549145
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Photoinduced RNA interference.
    Matsushita-Ishiodori Y; Ohtsuki T
    Acc Chem Res; 2012 Jul; 45(7):1039-47. PubMed ID: 22360585
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Calcium-MicroRNA Complex-Functionalized Nanotubular Implant Surface for Highly Efficient Transfection and Enhanced Osteogenesis of Mesenchymal Stem Cells.
    Song W; Yang C; Svend Le DQ; Zhang Y; Kjems J
    ACS Appl Mater Interfaces; 2018 Mar; 10(9):7756-7764. PubMed ID: 29420881
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Caveolin-1 and CDC42 mediated endocytosis of silica-coated iron oxide nanoparticles in HeLa cells.
    Bohmer N; Jordan A
    Beilstein J Nanotechnol; 2015; 6():167-76. PubMed ID: 25671161
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ultrasound and microbubble-targeted delivery of macromolecules is regulated by induction of endocytosis and pore formation.
    Meijering BD; Juffermans LJ; van Wamel A; Henning RH; Zuhorn IS; Emmer M; Versteilen AM; Paulus WJ; van Gilst WH; Kooiman K; de Jong N; Musters RJ; Deelman LE; Kamp O
    Circ Res; 2009 Mar; 104(5):679-87. PubMed ID: 19168443
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.